Saba Ghassemi
University of Pennsylvania
H-index: 19
North America-United States
Top articles of Saba Ghassemi
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells | 2024/2/13 | ||
Methods of making chimeric antigen receptor-expressing cells | 2020/9/2 | ||
Innovative Approaches to Enhance Chimeric Antigen Receptor (CAR) T-Cell Potency Using Quiescent T Cells | Saba Ghassemi | 2023/7/1 | |
Immunotherapy: BIOMECHANICS OF NAIVE T-CELLS AND THE APPLICATION TO MICROFLUIDIC-BASED DELIVERY FOR GENE EDITING | Cytotherapy | CA Colón T Yu S Ghassemi T Sulchek | 2023/5/1 |
A bioengineered immunocompetent human leukemia chip for preclinical screening of CAR T cell immunotherapy | Research Square | Chao Ma Huishu Wang Lunan Liu Jie Tong Matthew T Witkowski | 2023/4/21 |
Type I Interferon Blockade Enhances Transduction Efficiency and Efficacy of Non-Activated CAR T Cells | Blood | Joseph Durgin Ashwin Sannecy Andre Kelly Roddy S O'Connor Saba Ghassemi | 2023/11/28 |
442-B IL-18-enhanced non-activated CAR T-cells for improved metabolic function and therapeutic efficacy | Joseph Durgin Ashwin Sannecy Nandana Mukherjee Xiaoling Jin Andre Kelly | 2023/11/1 | |
Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase | Molecular Therapy | Joseph S Durgin Radhika Thokala Lexus Johnson Edward Song John Leferovich | 2022/3/2 |
Rapid manufacturing of non-activated potent CAR T cells | Nature biomedical engineering | Saba Ghassemi Joseph S Durgin Selene Nunez-Cruz Jai Patel John Leferovich | 2022/2 |
Computational model of CAR T-cell immunotherapy dissects and predicts leukemia patient responses at remission, resistance, and relapse | Journal for ImmunoTherapy of Cancer | Lunan Liu Chao Ma Zhuoyu Zhang Matthew T Witkowski Iannis Aifantis | 2022 |
395 Engineering non-activated CAR T cells with enhanced potency against advanced cancers | J Immunother | Saba Ghassemi Joseph Durgin Frederic Bushman Saar Gill Roddy O’Connor | 2022 |
1238 Separating the wheat from the chaff: Engineering CARTs with superior metabolic attributes against solid tumors | J Immunother | Yufan Zhou Andre Kelly Andrew Frisch Decheng Song Saba Ghassemi | 2022 |
Metabolic and epigenetic orchestration of (CAR) T cell fate and function | Behnia Akbari Zahra Hosseini Pardis Shahabinejad Saba Ghassemi Hamid Reza Mirzaei | 2022/12/1 | |
Genetic modification of cytokine signaling to enhance efficacy of CAR T cell therapy in solid tumors | Navid Ghahri-Saremi Behnia Akbari Tahereh Soltantoyeh Jamshid Hadjati Saba Ghassemi | 2021/10/14 | |
CAR T-cells depend on the coupling of NADH oxidation with ATP production | Cells | Juan C Garcia-Canaveras David Heo Sophie Trefely John Leferovich Chong Xu | 2021/9/6 |
Epigenetic strategies to boost CAR T cell therapy | Behnia Akbari Navid Ghahri-Saremi Tahereh Soltantoyeh Jamshid Hadjati Saba Ghassemi | 2021/9/1 | |
Novel media formulations to enhance chimeric antigen receptor (CAR) T-cell potency and anti-tumor cell function for adoptive immunotherapy | Cytotherapy | S Ghassemi F Martinez-Becerra A Master SA Richman D Heo | 2020/5/1 |
Enhancing chimeric antigen receptor T cell anti-tumor function through advanced media design | Molecular Therapy-Methods & Clinical Development | Saba Ghassemi Francisco J Martinez-Becerra Alyssa M Master Sarah A Richman David Heo | 2020/9/11 |
Chimeric Antigen Receptor (CAR) T cells on demand: developing potent CAR T cells in less than 24 hr for adoptive immunotherapy | Cytotherapy | S Ghassemi R O'Connor S Nunez-Cruz J Leferovich J Patel | 2020/5/1 |
